MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹15 Cr | ₹9.00 Cr | ₹5.38 Cr | ₹7.25 Cr | ₹0.70 Cr |
What is the latest Capital Work in Progress ratio of MARKSANS PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹15 Cr |
| Mar2025 | ₹9.00 Cr |
| Mar2024 | ₹5.38 Cr |
| Mar2023 | ₹7.25 Cr |
| Mar2022 | ₹0.70 Cr |
How is Capital Work in Progress of MARKSANS PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | 64.24 | |
| Mar2025 | ₹9.00 Cr | 67.26 | |
| Mar2024 | ₹5.38 Cr | -25.74 | |
| Mar2023 | ₹7.25 Cr | 942.59 | |
| Mar2022 | ₹0.70 Cr | - | |
Compare Capital Work in Progress of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,932.9 Cr | 1.7% | 27.4% | 81.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.7% |
27.4% |
81.2% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses